These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 38015853

  • 1. Characterization and applications of glutaminase free L-asparaginase from indigenous Bacillus halotolerans ASN9.
    Shafqat I, Shahzad S, Yasmin A, Chaudhry MT, Ahmed S, Javed A, Afzal I, Bibi M.
    PLoS One; 2023; 18(11):e0288620. PubMed ID: 38015853
    [Abstract] [Full Text] [Related]

  • 2. Production and Anticancer Activity of an L-Asparaginase from Bacillus licheniformis Isolated from the Red Sea, Saudi Arabia.
    Alrumman SA, Mostafa YS, Al-Izran KA, Alfaifi MY, Taha TH, Elbehairi SE.
    Sci Rep; 2019 Mar 06; 9(1):3756. PubMed ID: 30842557
    [Abstract] [Full Text] [Related]

  • 3. Biochemical characterization of glutaminase-free L-asparaginases from Himalayan Pseudomonas and Rahnella spp. for acrylamide mitigation.
    Patial V, Kumar S, Joshi R, Singh D.
    Int J Biol Macromol; 2024 Feb 06; 257(Pt 2):128576. PubMed ID: 38048933
    [Abstract] [Full Text] [Related]

  • 4. Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties.
    Mahajan RV, Kumar V, Rajendran V, Saran S, Ghosh PC, Saxena RK.
    PLoS One; 2014 Feb 06; 9(6):e99037. PubMed ID: 24905227
    [Abstract] [Full Text] [Related]

  • 5. Glutaminase-free L-asparaginase production by Leucosporidium muscorum isolated from Antarctic marine-sediment.
    Freire RKB, Mendonça CMN, Ferraro RB, Moguel IS, Tonso A, Lourenço FR, Santos JHPM, Sette LD, Pessoa Junior A.
    Prep Biochem Biotechnol; 2021 Feb 06; 51(3):277-288. PubMed ID: 32921254
    [Abstract] [Full Text] [Related]

  • 6. Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.
    Saeed H, Hemida A, El-Nikhely N, Abdel-Fattah M, Shalaby M, Hussein A, Eldoksh A, Ataya F, Aly N, Labrou N, Nematalla H.
    Int J Biol Macromol; 2020 Aug 01; 156():812-828. PubMed ID: 32311402
    [Abstract] [Full Text] [Related]

  • 7. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK, Horvath TD, Tan L, Link T, Harutyunyan KG, Pontikos MA, Anishkin A, Du D, Martin LA, Yin E, Rempe SB, Sukharev S, Konopleva M, Weinstein JN, Lorenzi PL.
    Mol Cancer Ther; 2019 Sep 01; 18(9):1587-1592. PubMed ID: 31209181
    [Abstract] [Full Text] [Related]

  • 8. Purification and biotechnological applications of L-asparaginase from newly isolated Bacillus halotolerans OHEM18 as antitumor and antioxidant agent.
    El-Fakharany E, Orabi H, Abdelkhalek E, Sidkey N.
    J Biomol Struct Dyn; 2022 Jun 01; 40(9):3837-3849. PubMed ID: 33228468
    [Abstract] [Full Text] [Related]

  • 9. Production, purification and kinetic characterization of glutaminase free anti-leukemic L-asparaginase with low endotoxin level from novel soil isolate.
    Prakash P, Singh HR, Jha SK.
    Prep Biochem Biotechnol; 2020 Jun 01; 50(3):260-271. PubMed ID: 31762381
    [Abstract] [Full Text] [Related]

  • 10. Aliivibrio fischeri L-Asparaginase production by engineered Bacillus subtilis: a potential new biopharmaceutical.
    Bento HBS, Paiva GB, Almeida MR, Silva CG, Carvalho PJ, Tavares APM, Pedrolli DB, Santos-Ebinuma VC.
    Bioprocess Biosyst Eng; 2022 Oct 01; 45(10):1635-1644. PubMed ID: 35974197
    [Abstract] [Full Text] [Related]

  • 11. Purification, characterization, and anticancer and antioxidant activities of L-glutaminase from Aspergillus versicolor Faesay4.
    Awad MF, El-Shenawy FS, El-Gendy MMAA, El-Bondkly EAM.
    Int Microbiol; 2021 May 01; 24(2):169-181. PubMed ID: 33389217
    [Abstract] [Full Text] [Related]

  • 12. Expression, characterization and cytotoxicity of recombinant l-asparaginase II from Salmonella paratyphi cloned in Escherichia coli.
    Abdullah EM, Khan MS, Aziz IM, Alokail MS, Karthikeyan S, Rupavarshini M, Bhat SA, Ataya FS.
    Int J Biol Macromol; 2024 Nov 01; 279(Pt 4):135458. PubMed ID: 39251007
    [Abstract] [Full Text] [Related]

  • 13. A new extracellular glutaminase and urease-free L-asparaginase from Meyerozyma guilliermondii.
    Ratuchne A, Izidoro SC, Beitel SM, Lacerda LT, Knob A.
    Braz J Microbiol; 2023 Jun 01; 54(2):715-723. PubMed ID: 36917331
    [Abstract] [Full Text] [Related]

  • 14. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A, Asad S, Kabiri M, Dabirmanesh B.
    Appl Microbiol Biotechnol; 2017 Oct 01; 101(19):7227-7238. PubMed ID: 28801829
    [Abstract] [Full Text] [Related]

  • 15. Purification and anticancer activity of glutaminase and urease free intracellular l-asparaginase from Chaetomium sp.
    Arumugam N, Thangavelu P.
    Protein Expr Purif; 2022 Feb 01; 190():106006. PubMed ID: 34742913
    [Abstract] [Full Text] [Related]

  • 16. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
    Kumar S, Venkata Dasu V, Pakshirajan K.
    Bioresour Technol; 2011 Jan 01; 102(2):2077-82. PubMed ID: 20832300
    [Abstract] [Full Text] [Related]

  • 17. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N, Mirzaie S, Sepahi AA, Khavari-Nejad RA.
    Med Hypotheses; 2018 Mar 01; 112():7-17. PubMed ID: 29447943
    [Abstract] [Full Text] [Related]

  • 18. Indicator dye based screening of glutaminase free L-asparaginase producer and kinetic evaluation of enzyme production process.
    Prakash P, Singh HR, Jha SK.
    Prep Biochem Biotechnol; 2020 Mar 01; 50(8):803-813. PubMed ID: 32163010
    [Abstract] [Full Text] [Related]

  • 19. Rational engineering and insight for a L-glutaminase activity reduced type II L-asparaginase from Bacillus licheniformis and its antileukemic activity in vitro.
    Zhou Y, Shen J, Chi H, Zhu X, Lu Z, Lu F, Zhu P.
    Int J Biol Macromol; 2024 Feb 01; 257(Pt 2):128690. PubMed ID: 38092107
    [Abstract] [Full Text] [Related]

  • 20. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.
    Sugimoto K, Suzuki HI, Fujimura T, Ono A, Kaga N, Isobe Y, Sasaki M, Taka H, Miyazono K, Komatsu N.
    Cancer Sci; 2015 Nov 01; 106(11):1534-43. PubMed ID: 26331698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.